BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23307531)

  • 1. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.
    Poole EM; Merritt MA; Jordan SJ; Yang HP; Hankinson SE; Park Y; Rosner B; Webb PM; Cramer DW; Wentzensen N; Terry KL; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):429-37. PubMed ID: 23307531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.
    Kotsopoulos J; Terry KL; Poole EM; Rosner B; Murphy MA; Hecht JL; Crum CP; Missmer SA; Cramer DW; Tworoger SS
    Int J Cancer; 2013 Aug; 133(3):730-9. PubMed ID: 23364849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.
    Shafrir AL; Rice MS; Gupta M; Terry KL; Rosner BA; Tamimi RM; Hecht JL; Tworoger SS
    Gynecol Oncol; 2016 Dec; 143(3):628-635. PubMed ID: 27720231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
    Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
    Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of phobic anxiety, risk of ovarian cancer, and survival among patients.
    Poole EM; Kubzansky LD; Sood AK; Okereke OI; Tworoger SS
    Cancer Causes Control; 2016 May; 27(5):661-8. PubMed ID: 27023470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual pain and epithelial ovarian cancer risk.
    Babic A; Cramer DW; Titus LJ; Tworoger SS; Terry KL
    Cancer Causes Control; 2014 Dec; 25(12):1725-31. PubMed ID: 25189423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and reproductive factors and the risk of ovarian cancer.
    Koushik A; Grundy A; Abrahamowicz M; Arseneau J; Gilbert L; Gotlieb WH; Lacaille J; Mes-Masson AM; Parent MÉ; Provencher DM; Richardson L; Siemiatycki J
    Cancer Causes Control; 2017 May; 28(5):393-403. PubMed ID: 28102526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of reproductive and hormonal factors on ovarian cancer survival.
    Nagle CM; Bain CJ; Green AC; Webb PM
    Int J Gynecol Cancer; 2008; 18(3):407-13. PubMed ID: 17645507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium.
    Fortner RT; Poole EM; Wentzensen NA; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Clendenen TV; Fournier A; Fraser G; Gapstur SM; Gaudet MM; Giles GG; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Kaaks R; Kirsh VA; Knutsen S; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Milne RL; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sánchez MJ; Schairer C; Schouten LJ; Tjonneland A; Townsend MK; Travis RC; Trichopoulou A; van den Brandt PA; Vineis P; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
    Int J Cancer; 2019 Jul; 145(1):58-69. PubMed ID: 30561796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.
    Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL
    Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
    Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
    Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
    Rice MS; Hankinson SE; Tworoger SS
    Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
    Risch HA; Marrett LD; Jain M; Howe GR
    Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
    Rasmussen CB; Kjaer SK; Albieri V; Bandera EV; Doherty JA; Høgdall E; Webb PM; Jordan SJ; Rossing MA; Wicklund KG; Goodman MT; Modugno F; Moysich KB; Ness RB; Edwards RP; Schildkraut JM; Berchuck A; Olson SH; Kiemeney LA; Massuger LF; Narod SA; Phelan CM; Anton-Culver H; Ziogas A; Wu AH; Pearce CL; Risch HA; Jensen A;
    Am J Epidemiol; 2017 Jan; 185(1):8-20. PubMed ID: 27941069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women.
    McGuire V; Hartge P; Liao LM; Sinha R; Bernstein L; Canchola AJ; Anderson GL; Stefanick ML; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1059-63. PubMed ID: 27197274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of reproductive factors and exogenous hormone use in relation to ovarian cancer risk among Black women.
    Bethea TN; Palmer JR; Adams-Campbell LL; Rosenberg L
    Cancer Causes Control; 2017 May; 28(5):385-391. PubMed ID: 28025764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
    Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
    Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.